Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 07 Mar 2023
People who have had a normal gastrointestinal (GI) biopsy are still at risk of developing inflammatory bowel disease (IBD) over the years...
Read Full NewsPrograms offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.
Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.
A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.
1.
Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.
2.
What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips?
3.
Study suggests radiation therapy benefits misjudged when clinical factors alone guide breast cancer treatment
4.
Skinny melanoma incidence is associated with vitamin D deficiency.
5.
Could semaglutide be used to treat addiction in addition to obesity?
1.
A Comprehensive Guide To Understanding Plasma Osmolality
2.
Red Blood Cell Aging and Clinical Implications
3.
Tumor Microenvironment Reprogramming in Cancer Treatment
4.
An Overview Of Daunorubicin: What Is It Used For And How Does It Work?
5.
Targeting BRAF V600E in mCRC: FOLFOX, Cetuximab & Encorafenib Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
2.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge